Disposition of 970 shares by Richard Waldron of Bioatla at 1.47 subject to Rule 16b-3
| BCAB Stock | USD 0.46 0.02 4.55% |
About 50% of Bioatla's investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Bioatla suggests that some traders are interested. The current market sentiment, together with Bioatla's historical and current headlines, can help investors time the market. In addition, many technical investors use Bioatla stock news signals to limit their universe of possible portfolio assets.
Bioatla |
Filed transaction by Bioatla Officer Chief Financial Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Read at macroaxis.com
Bioatla Fundamental Analysis
We analyze Bioatla's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bioatla using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bioatla based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Bioatla is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Bioatla Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bioatla stock to make a market-neutral strategy. Peer analysis of Bioatla could also be used in its relative valuation, which is a method of valuing Bioatla by comparing valuation metrics with similar companies.
Peers
Bioatla Related Equities
| PASG | Passage Bio | 7.69 | ||||
| STTK | Shattuck Labs | 6.40 | ||||
| ANTX | AN2 Therapeutics | 4.67 | ||||
| OLMA | Olema Pharmaceuticals | 2.90 | ||||
| DSGN | Design Therapeutics | 2.77 | ||||
| IPSC | Century Therapeutics | 2.67 | ||||
| ACRV | Acrivon Therapeutics, | 1.12 | ||||
| GLUE | Monte Rosa | 0.89 | ||||
| KYMR | Kymera Therapeutics | 0.68 | ||||
| NRIX | Nurix Therapeutics | 0.11 | ||||
| AVTE | Aerovate Therapeutics | 0.41 | ||||
| FHTX | Foghorn Therapeutics | 0.49 | ||||
| NAUT | Nautilus Biotechnology | 0.58 | ||||
| CCCC | C4 Therapeutics | 0.63 | ||||
| PMVP | Pmv Pharmaceuticals | 2.11 | ||||
| IKNA | Ikena Oncology | 2.61 | ||||
| ADAG | Adagene | 2.76 | ||||
| ERAS | Erasca | 3.68 | ||||
| RZLT | Rezolute | 4.16 |
Complementary Tools for Bioatla Stock analysis
When running Bioatla's price analysis, check to measure Bioatla's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioatla is operating at the current time. Most of Bioatla's value examination focuses on studying past and present price action to predict the probability of Bioatla's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioatla's price. Additionally, you may evaluate how the addition of Bioatla to your portfolios can decrease your overall portfolio volatility.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |